Kinase inhibitors in the treatment of chronic hepatitis C virus

Gut. 2011 Jun;60(6):879-80. doi: 10.1136/gut.2010.212068. Epub 2010 Oct 21.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Erlotinib Hydrochloride
  • Fatal Outcome
  • Follow-Up Studies
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Liver Transplantation
  • Male
  • Protein Kinase Inhibitors / therapeutic use*
  • Quinazolines / therapeutic use*

Substances

  • Antiviral Agents
  • Protein Kinase Inhibitors
  • Quinazolines
  • Erlotinib Hydrochloride